Drug Trial Radar · NCT03830125
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Jan 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
88
Actual
Start
Feb 13, 2019
Primary completion
Nov 24, 2019
Study completion Nov 24, 2019
Sponsor
- Lead sponsor
- Bridge Biotherapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- KCRN Research, LLC
- First posted
- Feb 5, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 19 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This clinical trial is the first-in-human study of BBT-877. The purpose of this phase 1 study is to assess the safety and tolerability of single and multiple ascending oral doses of BBT-877 in healthy adult subjects.
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
BBT-877, Single doseDrug
Single dose of BBT-877, 5 dose levels, oral capsule
Placebo groupDrug
Placebo matched to BBT-877, oral capsule
BBT-877, Multiple dosesDrug
Multiple doses of BBT-877, 14 days, 8 dose levels, oral capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number and severity of treatment emergent adverse events (TEAEs)Time frame: 7 days after the last dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.